Medication and Device Labelling
Labelling of injectable medicines and fluids and the devices used to deliver these (including non-labelling) has been identified as a patient safety issue. Safe use of medicines is a key component of Quality Use of Medicines (QUM), which forms part of Australia’s National Medicines Policy.
In 2012 the Australian Commission in Quality and Safety in Health Care released their publication National Recommendations for User-applied Labelling of Injectable Medicines, Fluids and Lines. The publication can be downloaded from here.The publication aims to:
- Promote safe use of injectable medicines
- Provide standardisation for user-applied labelling of injectable medicines
- Provide minimum requirements for user-applied labelling of injectable medicines
IntelliLearn’s Medication and Device Labelling course is mapped directly to the Commission’s publication.
Medication and Device Labelling and Med+Safe form IntelliLearn's Medication Safety library and offer organisations the opportunity to address education and compliance in these high risk areas.